"5-year commitment to the ECVIM-CA congress"
ROYAL CANIN® is a specialist provider of veterinary clinical and life stage diets for dogs and cats of all ages, sizes, breeds and physiological states.
Established in 1967 in Aimargues, France, ROYAL CANIN® is now a major global provider of nutritional solutions to the professional animal healthcare sectors.
With an ‘animal first’ approach, our dietary innovations have led to positive impacts in pet health worldwide and some examples include:
• Anallergenic - incorporating an extreme feather hydrolysate
• Fibre Response - to help manage chronic constipation in cats
• Gastro-Intestinal Low Fat in the case of canine pancreatitis
Royal Canin is a sponsoring partner of ECVIM-CA and is committed to promoting interest in clinical nutrition amongst young vets. Our strong ties with the veterinary profession make ROYAL CANIN® an adaptable partner in practice; providing not only highly scientific and cutting edge products, but service propositions including practice support and innovative digital tools.
Please also visit the new Veterinary Focus website:http://vetfocus.royalcanin.com
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
Boehringer Ingelheim Animal Health Business Unit
Boehringer Ingelheim is the second largest animal health business in the world. We are committed to creating animal wellbeing through our large portfolio of advanced, preventive healthcare products and services. With net sales of €3.9 billion and around 10,000 employees worldwide, we are present in more than 150 markets.
Nestlé Purina is a world leading Petfood Company with a dedicated research network around the world (Europe, US and Asia) where veterinarians, nutritionists and other scientists work together to develop and analyse new concepts in carefully designed feeding studies. Molecular nutrition and genetics, the benefits of controlled caloric intake and studies on diabetes mellitus, obesity, renal health, aging, adverse food reactions and intestinal health are examples of some of our research areas. Our scientists collaborate with prestigious universities, veterinary schools and vet clinics around the world to validate product performance. Our range of PRO PLAN products deliver specialized nutrition for all cats and dogs and sustain optimal health. Purina Pro Plan Veterinary Diets provides a concise, effective and comprehensive range of clinical diets to meet the special needs of dogs and cats with specific clinical conditions. We are proud to support ECVIM as it provides you with the latest scientific news you deserve. We will be pleased to welcome you on our booth. Enjoy this congress!